TLDRs;
- On Friday, during light holiday trading, Rocket Lab’s shares dropped by 8.46%, triggering discussions about the stock’s momentum at the end of the year.
- Despite short – term setbacks, the company’s $816 million Space Force contract enhances its long – term growth prospects.
- Rocket Lab concluded 2025 with a record of 21 successful Electron launches, demonstrating strong operational reliability.
- Wall Street remains split on RKLB, with price targets ranging from $61 to $90, indicating mixed levels of optimism.
On Friday, Rocket Lab (NASDAQ: RKLB) closed at $70.65, a 8.46% decline from Thursday’s levels. It fluctuated between $70.39 and $76.99 on an unusually low holiday trading volume of 23.16 million shares.
Investors mainly attributed the drop to profit – taking and low market liquidity, which often magnifies price swings during post – Christmas trading sessions.
Analysts pointed out that RKLB’s volatility reflects a broader decline in space – focused stocks, following a year of rapid gains driven by government contracts and a successful launch schedule.
Defense Contract Fuels Long – Term Bull Case
Despite the short – term pullback, on December 19, Rocket Lab announced an $816 million prime contract from the U.S. Space Development Agency (SDA) to produce 18 satellites for the Tracking Layer Tranche 3 program.
This award places Rocket Lab among defense and aerospace giants like Lockheed Martin and Northrop Grumman, with total Tranche 3 orders reaching approximately $3.5 billion.
CEO Sir Peter Beck emphasized that the deal shows Rocket Lab’s ability to compete as a vertically integrated national – security prime contractor, and additional “merchant supplier” opportunities could push the total capture value close to $1 billion.
Record Launches Highlight Execution Reliability
Rocket Lab ended 2025 with operational milestones that continue to impress investors. On December 21, the company completed its 21st Electron launch of the year, setting a new annual record with a 100% mission success rate.
Consistent launch success is a vital factor in securing both commercial and government clients, increasing confidence in Rocket Lab’s ability to turn contracts into revenue.
Both analysts and investors view the launch record as solid evidence of execution, especially as the company prepares for its medium – lift Neutron rocket, which is expected to arrive at Launch Complex 3 in early Q1 2026.
Wall Street Divided on Stock Outlook
Analyst opinions on RKLB are still divided. Needham raised its price target to $90, citing the SDA contract and potential follow – on revenue streams, while consensus estimates from TipRanks and MarketBeat average between $61 and $68.25.
Some firms, such as Cantor Fitzgerald, maintain overweight positions but are cautious at current price levels, stressing the need for continued operational milestones and revenue growth to justify valuations.
Investors will closely monitor the company’s Q4 2025 earnings report, expected in early March 2026, for updated guidance on revenue, margins, and EBITDA performance.
Looking Ahead to Monday Trading
As [it] enters the new week, investors face a clear trade – off between short – term volatility and long – term growth. Key factors to watch include whether the stock can stabilize above post – selloff levels, the achievement of SDA contract milestones, early Neutron launch results, and sector – wide space tech developments.
Even with Friday’s pullback, Rocket Lab’s story remains centered around tangible results and a growing defense – space presence, which may continue to attract institutional investors looking to invest in a maturing, high – growth aerospace company.
Rocket Lab’s stock has undergone a sharp end – of – year correction, but the company’s operational achievements and defense contract backlog still support a bullish long – term view. As RKLB moves into 2026, investors will balance near – term volatility against a strong execution record and strategic growth opportunities.
